REGN 740.39 (-0.4%)
US75886F1075BiotechnologyBiotechnology

Regeneron Pharmaceuticals (REGN) Financial Metrics

This table shows a selected set of financial data points of Regeneron Pharmaceuticals (REGN). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 37.05 0 23.7 93.71B 0.13 13.12B 3.67B 5.13B 3.95B 2.73B
2022 40.51 0 17.81 77.27B 0.16 12.17B 3.4B 5.5B 4.34B 3.11B
2021 76.4 0 8.27 66.75B 0.38 16.07B 6.53B 9.33B 8.08B 2.89B
2020 32.65 0 14.8 51.98B 0.22 8.5B 2B 4.1B 3.51B 2.19B
2019 19.38 0 19.38 41B 0.16 7.86B 2B 2.21B 2.12B 1.62B
2018 21.29 0 17.54 42.88B 0.24 6.71B 1.81B 2.73B 2.44B 1.47B
2017 10.34 0 36.37 43.59B 0.15 5.87B 1.03B 2.25B 1.2B 812.73M
2016 7.7 0 47.7 42.72B 0.14 4.86B 961.46M 1.44B 895.52M 535.2M
2015 5.52 0 98.35 62.55B 0.13 4.1B 652.85M 1.31B 636.06M 809.1M
2014 3.07 0 133.67 46.53B 0.1 2.82B 410.15M 865.81M 348.07M 648.72M
2013 3.81 0 72.18 30.63B 0.17 2.1B 427.33M 801M 424.36M 535.61M
2012 6.5 0 26.31 19.74B 0.44 1.38B -123.95M 496.67M 750.27M 230.28M
2011 -2.45 0 -22.65 5.02B -0.18 445.82M -198.9M -170.53M -221.76M 483.61M
2010 -1.26 0 -26.06 2.72B -0.11 459.07M -3.35M -75.66M -104.47M 112.57M
2009 -0.85 0 -28.44 1.93B -0.1 379.27M -169.55M -55.37M -67.83M 207.08M
2008 -1.05 0 -17.5 1.45B -0.1 238.46M -123.94M -61.32M -82.71M 247.8M
2007 -1.59 0 -15.17 1.6B -0.14 125.02M 8.93M -94.11M -105.6M 498.93M
2006 -1.77 0 -11.37 1.16B -0.2 63.45M 20.26M -87.75M -102.34M 237.88M
2005 -1.71 0 -9.32 889.61M -0.21 66.19M -35.26M -79.94M -95.45M 184.51M
2004 0.74 0 12.45 518.98M 0.09 174.02M -23.08M 57.06M 41.7M 101.23M
2003 -2.13 0 -6.91 742.12M -0.25 57.5M -35.79M -94.52M -107.46M 118.29M
2002 -2.83 0 -6.54 813.5M -0.28 21.99M -144.89M -115.92M -124.38M 80.08M
2001 -1.81 0 -15.56 1.19B -0.22 21.97M -65.54M -70.1M -76.18M 247.39M
2000 -0.66 0 -53.43 1.24B -0.13 59.28M -34.41M -18.79M -23.22M 30.98M
1999 -0.73 0 -17.36 400.98M -0.16 34.5M -19.5M -19.7M -23.1M 23.7M
1998 -0.28 0 -26.59 228.63M -0.05 38.2M -13.2M -5.6M -8.6M 19.8M
1997 -0.4 0 -21.41 248.31M -0.08 33.1M -8.2M -7.2M -11.6M 28.9M
1996 -1.32 0 -12.18 394.47M -0.28 24.1M -28.9M -26.3M -32.4M 34.5M
1995 -1.19 0 -10.71 251.79M -0.5 27.4M -21.5M -17.6M -23.5M 32.7M
1994 -1.62 0 -1.85 56.85M 0 23.2M -27.4M -26.5M -30.7M 0
1993 -2.41 0 -6.43 256.62M 0 10.6M -40.3M -36.8M -39.9M 0
1992 -1.24 0 -9.68 184.84M 0 11.5M -19.3M -17.1M -19.1M 0
1991 -0.29 0 -62.5 281.25M 0 7.3M -7.8M -3.7M -4.5M 0
1990 -0.21 0 0 0 0 5M 0 -3M -3.3M 0

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.